Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II efficacy study cannabinoid-based ointment for the treatment of Psoriasis: Psoriasis Study

Trial Profile

A Phase II efficacy study cannabinoid-based ointment for the treatment of Psoriasis: Psoriasis Study

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 05 Aug 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Sponsors One World Cannabis
  • Most Recent Events

    • 05 Aug 2019 According to an OWC Pharmaceutical Research Corp media release, currently, this study is planned to be conducted at the Kaplan Medical Center, an academic medical center in Israel.
    • 05 Aug 2019 According to an OWC Pharmaceutical Research Corp media release, it received long-awaited approval from the Israeli Medical Cannabis Agency to conduct this trial.
    • 30 Jan 2019 According to an OWC Pharmaceutical Research Corp media release, this study is expected to initiate during the third quarter 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top